Normal liver cells mainly produce glutaminase2 (GLS2); however, in the progression of liver cancer, an alteration in metabolism driven by the MYC gene shifts the expression from GLS2 to GLS1, supporting the altered glutamine metabolism that occurs in HCC tumor cells [137]. The gene discussed is GLS; the disease is hepatocellular carcinoma.